Web16 mei 2024 · Isavuconazole (ISA), the most recently introduced triazole, is an appealing option for both treatment and prophylaxis of invasive fungal infections (IFIs) in patients … WebDownload scientific diagram Breakthrough Invasive Fungal Infections During Isavuconazole, Posaconazole, and Voriconazole Primary Prophylaxis in Patients …
Isavuconazole prophylaxis against invasive fungal infections in ...
Web20 feb. 2024 · Isavuconazole is a broad-spectrum triazole approved for treatment of invasive fungal infections (IFIs). In this open-label, single-arm study, we evaluated isavuconazole for antifungal prophylaxis after allogeneic … WebAntifungal Resistance and the Role of New Therapeutic Agents. × Close Log In. Log in with Facebook Log in with Google. or. Email. Password. Remember me on this computer. or reset password. Enter the email address you signed up with and we'll email you a reset link. Need an account? Click here to sign up. Log In Sign Up. Log In; Sign Up; more ... professional email copy and paste
异基因造血干细胞移植中真菌二级预防的研究进展 - 中华器官移植 …
WebFinally, the fungemia was successfully treated with an isavuconazole-based therapy. Eleven months later (to date with the current report), the patient is still in complete … WebWe retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leukemia. Keywords breakthrough Web20 mrt. 2024 · Invasive fungal infections are a major cause of morbidity and mortality among patients, particularly those with a compromised immune system. According to … relocation aarhus